Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Schultz

Showing results (211-220 of 250) with videos related to

Pageof 25
Sort By:
Plos One|April 22, 2016
Sphingosine-1-Phosphate Lyase Deficient Cells as a Tool to Study Protein Lipid InteractionsMathias J Gerl, Verena Bittl, Susanne Kirchner, et al.
Research Square|September 2, 2025
SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary diseaseSebastien Boutin, Dario Frey, Barbara Helm, et al.
Journal of Lipid Research|July 14, 2025
Integrated lipidomic and proteomic profiling reveals metabolic network disruption by SARS-CoV-2 variantsScotland E Farley, Jennifer E Kyle, Helene Jahn, et al.
EMBO Reports|November 3, 2020
Inositol-requiring enzyme-1 regulates phosphoinositide signaling lipids and macrophage growthSyed Muhammad Hamid, Mevlut Citir, Erdem Murat Terzi, et al.
Journal of the American Chemical Society|May 30, 2020
Optical Control of Lysophosphatidic Acid SignalingJohannes Morstein, Mélanie A Dacheux, Derek D Norman, et al.
Oncotarget|June 15, 2018
Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemiaJoachim R Göthert, Roze Imsak, Michael Möllmann, et al.
Journal of Medicinal Chemistry|June 19, 2013
Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound designAndré Richters, Julia Ketzer, Matthäus Getlik, et al.
Angewandte Chemie (International Ed. in English)|January 21, 2017
A PDE6δ-KRas Inhibitor Chemotype with up to Seven H-Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2Pablo Martín-Gago, Eyad K Fansa, Christian H Klein, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 8, 2025
The present and future of cardiological telemonitoring in Europe: a statement from seven European countriesThomas M Helms, Giuseppe Boriani, Hans-Peter Brunner-La Rocca, et al.
Journal of Medicinal Chemistry|August 31, 2017
Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor ReceptorJulian Engel, Steven Smith, Jonas Lategahn, et al.
Pageof 25

Showing results (211-220 of 250) with videos related to

Sort By:
Pageof 25
Plos One|April 22, 2016
Sphingosine-1-Phosphate Lyase Deficient Cells as a Tool to Study Protein Lipid InteractionsMathias J Gerl, Verena Bittl, Susanne Kirchner, et al.
Research Square|September 2, 2025
SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary diseaseSebastien Boutin, Dario Frey, Barbara Helm, et al.
Journal of Lipid Research|July 14, 2025
Integrated lipidomic and proteomic profiling reveals metabolic network disruption by SARS-CoV-2 variantsScotland E Farley, Jennifer E Kyle, Helene Jahn, et al.
EMBO Reports|November 3, 2020
Inositol-requiring enzyme-1 regulates phosphoinositide signaling lipids and macrophage growthSyed Muhammad Hamid, Mevlut Citir, Erdem Murat Terzi, et al.
Journal of the American Chemical Society|May 30, 2020
Optical Control of Lysophosphatidic Acid SignalingJohannes Morstein, Mélanie A Dacheux, Derek D Norman, et al.
Oncotarget|June 15, 2018
Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemiaJoachim R Göthert, Roze Imsak, Michael Möllmann, et al.
Journal of Medicinal Chemistry|June 19, 2013
Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound designAndré Richters, Julia Ketzer, Matthäus Getlik, et al.
Angewandte Chemie (International Ed. in English)|January 21, 2017
A PDE6δ-KRas Inhibitor Chemotype with up to Seven H-Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2Pablo Martín-Gago, Eyad K Fansa, Christian H Klein, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 8, 2025
The present and future of cardiological telemonitoring in Europe: a statement from seven European countriesThomas M Helms, Giuseppe Boriani, Hans-Peter Brunner-La Rocca, et al.
Journal of Medicinal Chemistry|August 31, 2017
Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor ReceptorJulian Engel, Steven Smith, Jonas Lategahn, et al.
Pageof 25